Asuragen, Inc. to Present Study Results on Differentially Expressed microRNA Biomarkers in Pancreatic FNA and FFPE Specimens at the Annual Meeting of the European Pancreatic Club in Poland

AUSTIN, Texas--(BUSINESS WIRE)--Today the Company announced that Anna Szafranska, Ph.D., Senior Scientist, will present latest study results on microRNA (miRNA) biomarkers that distinguish benign pancreatic tissues from malignant tissues at the Joint Meeting of the European Pancreatic Club (EPC) and the International Association of Pancreatology (IAP) in Lodz, Poland, June 25-28, 2008.